Metin Yazar

Metin Yazar

Auto-generated profile, based on publicly available information

Metin Yazar

Department of Medical Genetics, Trakya University Medical Faculty, Edirne, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2014 in Andrologia
Verified
Journal Article
Closed access
PDF file
HGHakan Gürkan
Hakan Gürkan
HTH. Tozkır
H. Tozkır
EGE. Göncü
E. Göncü
SUS. Ulusal
S. Ulusal
MYM. Yazar
M. Yazar
Methylenetetrahydrofolate reductase (MTHFR), the key enzyme of the folate metabolic pathway, has been reported to be five times more active in the testicles compared to other organs in adult mice. The aim of this study was to investigate the relationship between MTHFR c.677C>T and c.1298A>C polymorphisms and infertility in nonobstructive azoospermic and oligozoospermic male patients living in the Trakya region of Turkey. The study population included 75 nonobstructive azoospermic and 62 oligozoospermic, nonconsanguineous patients who were referred to the Department of Medical Genetics of Trakya University between 01.03.2012 and 01.06.2013 due to infertility and who had been diagnosed based on clinical examinations and spermiograms. All of the patients had a normal karyotype without a Y chromosome microdeletion. Melting curve analysis with labelled probes and primers that were designed by the manufacturers and the real-time polymerase chain reaction method were used. The MTHFR c.677TT genotype frequency in the oligozoospermic infertile male patient group was greater than that of the fertile control group [odds ratio (OR) = 2.675 (95% CI: 0.979-7.305), (P < 0.048)]. The MTHFR c.677TT genotype may be a genetic risk factor for oligozoospermic infertile male patients who live in the Trakya region of Turkey.

26 March 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
MYMetin Yazar
Metin Yazar
POPemra Ozbek
Pemra Ozbek

10 September 2014 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
OPOmer Nuri Pamuk
Omer Nuri Pamuk
HTHilmi Tozkir
Hilmi Tozkir
MUMehmet Sevki Uyanik
Mehmet Sevki Uyanik
HGHakan Gurkan
Hakan Gurkan
FSFatih Saritas
Fatih Saritas
GPGulsum Emel Pamuk
Gulsum Emel Pamuk

8 October 2014 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
HTHilmi Tozkir
Hilmi Tozkir
OPOmer Nuri Pamuk
Omer Nuri Pamuk
JDJulide Duymaz
Julide Duymaz
HGHakan Gurkan
Hakan Gurkan
MYMetin Yazar
Metin Yazar
GPGulsum Emel Pamuk
Gulsum Emel Pamuk

1 August 2019 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
EÖElif Kubat Öktem
Elif Kubat Öktem
MYMetin Yazar
Metin Yazar
GGGizem Gulfidan
Gizem Gulfidan
KAKazim Yalcin Arga
Kazim Yalcin Arga
Urodele amphibians such as the axolotl ( Ambystoma mexicanum ) display a large capacity for tissue regeneration and remarkable resistance to cancer. As a model organism, axolotl thus offers a unique opportunity for cancer research and anticancer drug discovery, not to mention the discerning mechanisms that underpin controlled cellular growth and regeneration versus cancer. To the best of our knowledge, little is known on comparative gene expression changes during regeneration events such as wound healing in axolotl and humans. Using publicly available transcriptomics data and bioinformatics analyses, we examined the differential gene expression signatures in skin wound samples from axolotl and humans after skin biopsy punch injury, in comparison with intact (uninjured) control skin samples. We identified 95 genes exhibiting a reversal expression pattern between humans and axolotl during the wound healing/regeneration period. These genes were significantly associated with collagen biosynthesis, extracellular matrix organization, PI3K-Akt signaling pathway, immune system response, and apoptotic process. Furthermore, this new gene set exhibited high prognostic performance in discriminating the survival risk in skin-related cancers, including melanoma (hazard ratio [HR] = 8.14, p < 10 −30 ), oral cancer (HR >100, p < 10 −12 ), and head and neck carcinoma (HR = 5.29, p < 10 −30 ). Moreover, considering these gene signatures, we repositioned 11 small molecules as potential anticancer drug candidates indicating reversal effects on upregulated human genes and downregulated axolotl genes or mimicking downregulated human genes and upregulated axolotl genes. We anticipate that this study offers new insights on gene signatures bridging regeneration mechanisms with tumorigenesis and cancer drug repositioning.

19 May 2020 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
MYMetin Yazar
Metin Yazar
POPemra Ozbek
Pemra Ozbek